U.S.-China Collaboration Could Cut Development Time, Cost For New Cancer Treatments

The world ’s current system for developing cancer drugs is unsustainable, Memorial Sloan Kettering oncologist Dr. Bob Li believes.

Source: Forbes.com Healthcare News - March 22, 2023 Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Tags: Asia /asia Business /business Policy /policy Innovation /innovation Healthcare /healthcare Science /science forbeschina Source Type: news